Exploring the Potential for Moral Hazard When Clinical Trial Research is Conducted in Rural Communities: Do Traditional Ethics Concepts Apply?

  title={Exploring the Potential for Moral Hazard When Clinical Trial Research is Conducted in Rural Communities: Do Traditional Ethics Concepts Apply?},
  author={A. Cook and H. Hoas},
  journal={HEC Forum},
Over the past 20 years, clinical research has migrated from academic medical centers to community-based settings, including rural settings. This evolving research environment may present some moral hazards or challenges that could undermine traditionally accepted standards for the protection of human subjects. The study described in this article was designed to explore the influence of motives driving the decisions to conduct clinical trial research in rural community settings. The researchers… Expand
4 Citations
Challenges with Healthcare in the Rural and Prairie Environment.
This symposium includes thirteen personal narratives from individuals who have learned, first-hand, what it means to provide healthcare services in rural or frontier communities in the United States.Expand
Introduction: Clinical Ethics Beyond the Urban Hospital
Bioethics, and subsequently clinical ethics, developed primarily out of concerns that arose in the context of urban academic acute-care medicine, and relied heavily (either consciously or subconsciously) on the particularities of this context for the creation of its most seminal concepts and practices. Expand
Exploring the Practical Meaning of Clinical Ethics When Providing Healthcare in Rural and Frontier Settings: Appreciating What Matters.
The authors juxtapose the insights, offered in the narratives, with the lessons learned from their more than twenty years of empirical bioethics research in rural communities. Expand


Clinicians or Researchers, Patients or Participants: Exploring Human Subject Protection When Clinical Research Is Conducted in Non-academic Settings
It is suggested that the current processes and protocols employed in non-academic research settings may not achieve optimal protection of human subjects and more research is needed in order to more fully understand how a combination of factors, including the financing of research, recruitment practices, and the blurred distinctions between research and treatment, may undermine the optimal protectionof human subjects. Expand
The Protectors and the Protected: What Regulators and Researchers Can Learn from IRB Members and Subjects
Light is shed on this evolving world of clinical research by discussing the findings gleaned from a study of the decision making processes used by members who serve on different kinds of IRBs and how the key findings may inform proposed revisions to the Common Rule. Expand
Exploring the Obligation to Inform: Disclosing the Purpose and Benefits of Research in an Increasingly Commercial Research Environment
This article draws on a subset of data from an empirical study supported by the National Science Foundation. The study explored how institutional review boards (IRBs) fulfill their obligations toExpand
“Ready-to-Recruit” or “Ready-to-Consent” Populations? Informed Consent and the Limits of Subject Autonomy
  • J. Fisher
  • Psychology, Medicine
  • Qualitative inquiry : QI
  • 2007
This article queries the pharmaceutical industry's concept of “ready-torecruit” populations by examining its recruitment strategies for clinical trials and the types of human subjects who participate in these drug studies and examines the impotence of informed consent. Expand
Ethics and Rural Healthcare: What Really Happens? What Might Help?
  • A. Cook, H. Hoas
  • Sociology, Medicine
  • The American journal of bioethics : AJOB
  • 2008
The key findings obtained from multi-method research studies conducted over a 9-year period of time in a multi-state rural area are presented and a framework for envisioning resources and approaches that may be more appropriate is offered. Expand
Research in the Physician's Office: Navigating the Ethical Minefield
An internist in private practice who works at an inner city clinic affiliated with a university hospital, and the company approaches Dr. Smith to be a coinvestigator in its multicenter clinical trial for its new oral hypoglycemic medicine. Expand
The Effects of Payment Method on Clinical Decision-Making: Physician Responses to Clinical Scenarios
Payment mechanism has significant effects on clinical decision-making, and reduction of resources spent for discretionary care might be achieved under capitated arrangements; however, physicians respond with greater levels of discomfort under capitation than FFS. Expand
Trading Places: What the Research Participant Can Tell the Investigator about Informed Consent
The results of this study create a framework for understanding the challenges of the current informed consent process and offers insights into what may be needed to create an environment that allows research participants to make more enlightened decisions. Expand
Oversight of Financial Conflicts of Interest in Commercially Sponsored Research in Academic and Nonacademic Settings
Nonacademic sites have substantially different approaches to the oversight and management of financial relationships in commercially sponsored clinical research than academic medical centers, and these differences warrant more attention in community research settings. Expand
The private practicing physician-investigator: ethical implications of clinical research in the office setting.
Drug companies are moving their research from academic medical centers to physicians' private offices, which could mean faster and better results, but also changes the physician's relationship to patients and could produce subjects who don't understand what they're participating in and results that are unreliable. Expand